Detalles de la búsqueda
1.
A RIPK1-specific PROTAC degrader achieves potent antitumor activity by enhancing immunogenic cell death.
Immunity
; 2024 May 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-38788712
2.
Isolated limb perfusion with biochemotherapy and oncolytic virotherapy combines with radiotherapy and surgery to overcome treatment resistance in an animal model of extremity soft tissue sarcoma.
Int J Cancer
; 139(6): 1414-22, 2016 09 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-27116656
3.
BRAF- and MEK-Targeted Small Molecule Inhibitors Exert Enhanced Antimelanoma Effects in Combination With Oncolytic Reovirus Through ER Stress.
Mol Ther
; 23(5): 931-942, 2015 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-25619724
4.
Isolated limb perfusion with melphalan, tumour necrosis factor-alpha and oncolytic vaccinia virus improves tumour targeting and prolongs survival in a rat model of advanced extremity sarcoma.
Int J Cancer
; 136(4): 965-76, 2015 Feb 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-24978211
5.
Phase II trial of intravenous administration of Reolysin(®) (Reovirus Serotype-3-dearing Strain) in patients with metastatic melanoma.
Mol Ther
; 20(10): 1998-2003, 2012 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-22871663
6.
Reovirus exerts potent oncolytic effects in head and neck cancer cell lines that are independent of signalling in the EGFR pathway.
BMC Cancer
; 12: 368, 2012 Aug 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-22920673
7.
CD4 T cell dynamics shape the immune response to combination oncolytic herpes virus and BRAF inhibitor therapy for melanoma.
J Immunother Cancer
; 10(3)2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-35338089
8.
Antiviral antibody responses to systemic administration of an oncolytic RNA virus: the impact of standard concomitant anticancer chemotherapies.
J Immunother Cancer
; 9(7)2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-34301814
9.
The PERK Inhibitor GSK2606414 Enhances Reovirus Infection in Head and Neck Squamous Cell Carcinoma via an ATF4-Dependent Mechanism.
Mol Ther Oncolytics
; 16: 238-249, 2020 Mar 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-32128359
10.
RIPK1-mediated immunogenic cell death promotes anti-tumour immunity against soft-tissue sarcoma.
EMBO Mol Med
; 12(6): e10979, 2020 06 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32419365
11.
Combination therapy with oncolytic viruses and immune checkpoint inhibitors.
Expert Opin Biol Ther
; 20(6): 635-652, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32067509
12.
Development of a new fusion-enhanced oncolytic immunotherapy platform based on herpes simplex virus type 1.
J Immunother Cancer
; 7(1): 214, 2019 08 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-31399043
13.
PD-1 Blockade Following Isolated Limb Perfusion with Vaccinia Virus Prevents Local and Distant Relapse of Soft-tissue Sarcoma.
Clin Cancer Res
; 25(11): 3443-3454, 2019 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30885937
14.
Combination strategies incorporating oncolytic viruses and immune checkpoint inhibitors for advanced melanoma: what is the evidence?
Ann Transl Med
; 11(10): 369, 2023 Aug 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-37675296
15.
Synergistic antitumour effects of rapamycin and oncolytic reovirus.
Cancer Gene Ther
; 25(5-6): 148-160, 2018 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29720674
16.
Genetically modified lentiviruses that preserve microvascular function protect against late radiation damage in normal tissues.
Sci Transl Med
; 10(425)2018 01 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-29367346
17.
Enhanced cytotoxicity of reovirus and radiotherapy in melanoma cells is mediated through increased viral replication and mitochondrial apoptotic signalling.
Oncotarget
; 7(30): 48517-48532, 2016 Jul 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-27384486
18.
Oncolytic vaccinia virus combined with radiotherapy induces apoptotic cell death in sarcoma cells by down-regulating the inhibitors of apoptosis.
Oncotarget
; 7(49): 81208-81222, 2016 Dec 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-27783991
19.
Trametinib radiosensitises RAS- and BRAF-mutated melanoma by perturbing cell cycle and inducing senescence.
Radiother Oncol
; 117(2): 364-75, 2015 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-26163092
20.
Phase I trial of cyclophosphamide as an immune modulator for optimizing oncolytic reovirus delivery to solid tumors.
Clin Cancer Res
; 21(6): 1305-12, 2015 Mar 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-25424857